Clincosm LogoSign in Get a demo

peripheral t cell lymphoma

Showing NaN - NaN of 5
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Peripheral T Cell Lymphoma, PTCL, Extranodal NK/T-cell Lymphoma Trial in Worldwide (Tislelizumab)

Completed
Has Results
  • Peripheral T Cell Lymphoma
  • +18 more
  • Vancouver, British Columbia, Canada
  • +29 more
Apr 29, 2022

Treatment-naïve, Peripheral T Cell Lymphoma Trial in Guangzhou (Dose-finding stage: Liposomal mitoxantrone HCl,

Recruiting
  • Treatment-naïve
  • Peripheral T Cell Lymphoma
  • Dose-finding stage: Liposomal mitoxantrone hydrochloride, Cyclophosphamide, Vincristine and Prednisone
  • Dose-expansion stage: Liposomal mitoxantrone hydrochloride, Cyclophosphamide, Vincristine and Prednisone
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Jul 26, 2021

Peripheral T Cell Lymphoma Trial in Guangzhou (Mitoxantrone Hydrochloride Liposome Injection, Chidamide)

Not yet recruiting
  • Peripheral T Cell Lymphoma
  • Mitoxantrone Hydrochloride Liposome Injection
  • Chidamide
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Dec 11, 2020

Peripheral T Cell Lymphoma Trial in Guangzhou (chidamide, cyclophosphamide, liposomal doxorubicin)

Unknown status
  • Peripheral T Cell Lymphoma
  • Guangzhou, Guangdong, China
    Ru Feng
Jan 13, 2017

Peripheral T Cell Lymphoma Trial in Guangzhou (Chidamide)

Unknown status
  • Peripheral T Cell Lymphoma
  • Guangzhou, Guangdong, China
    Guangdong general hospital
Oct 24, 2016